AMERISAFE, Inc.
NASDAQAMSF has shed nearly 10% over the past week to $30.24, a meaningful deterioration since Q2 results landed — and the analyst community responded quickly, with Truist Securities cutting its price target to $32 from $34 yesterday while maintaining a Hold rating. That target trim is the clearest post-print signal from the Street. Truist has now lowered its target four times in the past…
AMSF cost to borrow surges to 0.82%, up 114% over the past week, marking the sharpest spike since early July amid thin availability and rising short pressure.
Snapshot as of 6 Sept 2026
AMSF has shed nearly 10% over the past week to $30.24, a meaningful deterioration since Q2 results landed — and the analyst community responded quickly, with Truist Securities cutting its price target to $32 from $34…
AMSF has reported Q2 results with the stock slipping 0.9% on Tuesday to $33.98, a muted reaction relative to the split performance seen across its insurance peer group. The peer picture is the most interesting contrast…
AMSF reports Q2 results today with one clear signal: short sellers have been pulling back even as the stock drifted lower. Short interest has fallen roughly 7% over the past week to 4.1% of the free float — a…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AMSF — free to start on ORTEX.
Sign up for free →Open AMSF on ORTEX